LIMATICA provides the new standard for cell aging. Like a "stethoscope" for battery cells - listen, analyze, react.
Limatica has raised $1.5M in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2024.
Limatica's investors include Heartfelt Capital, kopa ventures, Bloomhaus Ventures.
Limatica is headquartered in Chemnitz, Germany.
LIMATICA provides the new standard for cell aging. Like a "stethoscope" for battery cells - listen, analyze, react.
Limatica is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Limatica — Funding & Investors." VCBacked, December 11, 2024, https://www.vcbacked.co/company/limatica. Accessed September 3, 2026.
VCBacked. (2024). Limatica — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/limatica
{{cite web |title=Limatica — Funding & Investors |url=https://www.vcbacked.co/company/limatica |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated